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Placement of self-expandable metallic stents with a laryngeal mask
and a fiberoptic flexible bronchoscope for obstructive tracheobronchial
lesions
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Yoshiaki Tanaba, MD, Iwate, Japan
Self-expandable metallic stents have been used in themanagement of malignant or benign tumors causing air-way stenosis or obstruction by means of a rigid bron-choscope or fluoroscopic control.1 However, fully
trained personnel are needed to manage the rigid bronchoscope,
and the sites to be reached with it are limited. Additionally,
mandibular arthrosis, or limited mouth opening, or spinal defor-
mities might present technical problems with the rigid broncho-
scope. On the other hand, it might often be difficult to achieve the
exact fitting of the stent under fluoroscopic control.
The laryngeal mask is a reusable device with a larger internal
diameter, allowing easier passage of a fiberoptic flexible broncho-
scope or instruments (Figure 1, A), and does not require the usual
endotracheal intubation or mask ventilation.2-5 In this report we
describe a procedure of inserting a self-expandable metallic stent
under direct visual control with the use of the new laryngeal mask
and a fiberoptic flexible bronchoscope in the management of
tracheobronchial obstructive lesions.
Patients and Methods
Stenting with a laryngeal mask and a flexible bronchoscope was
performed after achievement of general anesthesia with a laryngeal
mask placement (Figure 1, B). Placement of the laryngeal mask
has been described elsewhere.5 Anesthesia was induced with
propofol (2.5-3.0 mg/kg) and maintained with sevoflurane in 67%
to 75% air. A muscle relaxant, such as vecuronium bromide, was
used when necessary. Before stenting, bronchoscopic surgery,
such as argon plasma coagulation or electrocautery, for airway
lesions was performed when necessary. For stent insertion, we
used a self-expandable metallic stent (Spiral Z stent; Medico’s
Hirata, Osaka, Japan). The flexible bronchoscope (BF P40; Olym-
pus, Tokyo, Japan) was passed through the slit of the cap of the
swivel connector (Portex Catheter Mount; SIMS Portex Inc, Kent,
United Kingdom), which connected the laryngeal mask and the
anesthesia machine. A guide wire through the working channel of
the flexible bronchoscope was introduced beyond the stenotic site.
After the bronchoscope was removed, a thin, fiberoptic flexible
bronchoscope (BF3C30; Olympus) was passed through the cap of
the slit of the swivel connector. The stent loader was also passed
through the slit of the laryngeal mask, and it was introduced into
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Figure 1. A, A laryngeal mask airway. B, Placement of the laryn-
geal mask. The deflated cuff of the laryngeal mask is introduced
into the hypopharynx with air to seal off the glottis.
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the laryngeal mask tube and trachea. Then the expandable metallic
stent that was passed through the stent loader was pushed out to sit
across the stenosis under bronchoscopic vision. When subsequent
fiberoptic bronchoscopy indicated the need to move the stent, it
was precisely moved into the correct location with the use of a
biopsy forceps. The entire procedure was performed without in-
terruption of ventilation during the procedure. Percutaneous oxy-
gen saturation with a pulse oximeter, blood pressure measurement,
and electrocardiographic results were monitored during the proce-
dure. Results were considered satisfactory when airway dilation at
the stenotic site or improved clinical symptoms or both were
achieved. Any outcome that did not accomplish the aims was
judged unsatisfactory.
Results and Discussion
Patients’ characteristics and results are summarized in Table 1.
Between April 1996 and December 2001, 12 patients aged 48 to 87
years (mean, 71 years) received tracheobronchial stent treatment.
The patients included 5 men and 7 women, having 1 benign tumor,
3 thyroid cancers, and 8 primary lung cancers.
Stent placement was successful in all patients. The stenotic
or obstructive site was successfully dilated in all patients, and
in 7 patients having symptoms, such as dyspnea, stridor, and
cough, the symptoms were relieved immediately after the op-
eration. Before the stent placement, 5 patients received argon
plasma coagulation for reduction of the tumor and dilation of
the airway stenosis or obstruction. In 1 (patient 4) of 4 patients
with thyroid cancer, an emergency argon plasma coagulation
for the endotracheal tumor, causing pinhole stenosis of the
subglottic trachea, was performed. Thereafter, a self-expand-
able metallic stent was placed. The patient’s symptoms, such as
dyspnea and stridor, were relieved promptly. In 1 patient (pa-
tient 1) with a benign thyroid tumor presenting stridor and
shortness of breath, an urgent surgical intervention for the
progressively deteriorating retinal detachment was indicated.
Thereafter, urgent endotracheal stenting under a flexible bron-
choscope and laryngeal mask placement at the stenosed site of
the upper trachea was performed, and subsequently, the surgical
retinal reattachment was followed by mild sore throat postop-
eratively, which spontaneously resolved.
TABLE 1. Patients’ characteristics and outcomes
Patient no.
(age [y], sex)
Disease
(histology) Site
Signs and
symptoms Stenosis
Laryngeal
mask
size
Operation
time (min)
Combined
therapy Result Complication Current status
1 (64, F) Thyroid tumor
(adeno)
UT Dyspnea,
Cough
95% 3 20 APC Satisfactory None 27 mo, alive
2 (48, M) Lung cancer
(adenoma)
RMB Dyspnea,
Cough
90% 4 14 APC Satisfactory None 3 mo, dead
3 (58, F) Thyroid cancer
(papillary adeno)
UT Bloody
sputum,
Stridor
85% 3 26 APC Satisfactory None 25 mo, alive
4 (62, F) Thyroid cancer
(papillary adeno)
UT Dyspnea,
Stridor
95% 3 15 APC Satisfactory None 3 mo, alive
5 (87, F) Thyroid cancer
(papillary adeno)
UT Bloody
sputum,
Stridor
90% 3 18 APC Satisfactory None 37 mo, alive
6 (78, F) Lung cancer (small
cell ca)
LMB Dyspnea,
Stridor
85% 3 22 None Satisfactory None 2 mo, dead
7 (78, F) Lung cancer
(adeno)
RMB Dyspnea,
Stridor
90% 3 25 None Satisfactory None 18 mo, dead
8 (80, F) Lung cancer
(adeno)
LMB Dyspnea,
Stridor
95% 3 22 None Satisfactory None 1 mo, dead
9 (67, M) Lung cancer (small
cell ca)
LMB Dyspnea,
Bloody
sputum
80% 4 30 None Satisfactory None 4 mo, alive
10 (79, M) Lung cancer
(squamous cell
ca)
TI Dyspnea,
Cough
100% 4 17 APC Satisfactory None 1 mo, dead
11 (72, M) Lung cancer
(adeno)
RMB Dyspnea,
bloody
sputum
90% 4 22 Electro-
cautery
Satisfactory None 5 mo, dead
12 (78, M) Lung cancer
(squamous cell
ca)
LMB Dyspnea,
bloody
sputum
90% 4 23 Electro-
cautery
Satisfactory None 2 mo, dead
Adeno, Adenocarcinoma; UT, upper trachea; APC, Argon plasma coagulation; RMB, right main bronchus; Ca, carcinoma; LMB, left main bronchus; TI,
Truncus Intermedius bronchus.
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The operating time ranged from 14 to 30 minutes (mean, 21
minutes). No complications, either related or unrelated to the
procedure, occurred in any of the patients. No deaths have oc-
curred from stent failure or related complications. Percutaneous
oxygen saturation, blood pressure, and electrocardiographic results
were not changed during the procedure. The delivery of the self-
expandable metallic stent within the airway by using the laryngeal
mask was easy and quick, without interrupting ventilation in all
patients. Also, positioning of the stent under the direct broncho-
scopic vision was easy and exact, without need of fluoroscopy.
Satisfactory results were achieved in all patients.
Our preliminary results showed that self-expandable metallic
stents can be inserted safely, quickly, and exactly with a laryngeal
mask and a fiberoptic flexible bronchoscope without the use of
fluoroscopy in the treatment of selected tracheobronchial tumors.
This new procedure will, however, require careful evaluation in
larger series.
The procedure, under general anesthesia, might be considered a
disadvantage, but the use of general anesthesia allowed no motion
of the patient and steady visualization of the airway during the
procedure reduced risky complications and reduced the operating
time.
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